← Eichor
Study identifier: NCT06023030 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

An Observational Study to Assess Change in Disease Activity and Adverse Events in Adolescent and Adult Participants With Moderate to Severe Active Crohn's Disease (CD) in Japan

Condition: Crohn's Disease  ·  Sponsor: AbbVie

PhaseN/A
Planned participants240
Who can joinAll sexes, 15 Years to no upper limit
Healthy volunteersNo

About this study

Crohn's disease (CD) is an incurable chronic inflammatory disorder of the gastrointestinal tract. This study will assess how safe and effective upadacitinib is in treating moderately to severely active CD in real world. Adverse events and change in disease activity will be assessed. Upadacitinib is a drug approved for the treatment of CD. All study participants will receive upadacitinib as prescribed by their study doctor in accordance with approved local label. Approximately 240 participants will be enrolled in Japan. Participants will receive upadacitinib as prescribed by their physician according to their routine clinical practice and local label. Participants will be followed for up to 64 weeks. There is expected to be no additional burden for participants in this trial. Study visits may be conducted on-site or virtually as per standard of care.

This description comes directly from the study's public registry record.

Talk to the study team

AbbVie GK Clinical Trial Registration Desk  ·  +81-3-4577-1111  ·  abbvie_jpn_info_clingov@abbvie.com

Always discuss trial participation with your own doctor first.

Locations (104)

Anjou Kousei Hospital /ID# 261872Anjo-shi, Aichi-ken, JapanRecruiting
Handa City Hospital /ID# 270446Handa, Aichi-ken, JapanRecruiting
Aichi Medical University Hospital /ID# 261871Nagakute, Aichi-ken, JapanRecruiting
Masuko Memorial Hospital /ID# 267420Nagoya, Aichi-ken, JapanRecruiting
Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital /ID# 276219Nagoya, Aichi-ken, JapanRecruiting
Nagoya City University Hospital /ID# 275588Nagoya, Aichi-ken, JapanRecruiting
Toyohashi Municipal Hospital /ID# 274975Toyohashi, Aichi-ken, JapanRecruiting
Ieda Hospital /ID# 259754Toyota-shi, Aichi-ken, JapanRecruiting
Hachinohe City Hospital /ID# 264183Hachinohe, Aomori, JapanRecruiting
Tsujinaka Hospital - Kashiwanoha /ID# 262648Kashiwa-shi, Chiba, JapanRecruiting
Matsuyama Red Cross Hospital /ID# 266717Matsuyama, Ehime, JapanRecruiting
Uwajima City Hospital /ID# 273444Uwajima, Ehime, JapanRecruiting

+ 92 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06023030